Search Results "#NF1"

Blogs

arrow_forward View More Results
Subcutaneous Neurofibroma Market: How Are MEK Inhibitors and Topical Therapies Redefining Management Beyond Surgical Excision?
Posted by Surbhi on July 28 2026 at 05:00 PM   public
Subcutaneous neurofibromas — the benign peripheral nerve sheath tumors arising within the dermis and subcutis, often multiple and disfiguring in neurofibromatosis type 1 (NF1) patients — have his...
MEK Inhibitors Market: How Is Neurofibromatosis Type 1 Approval Creating a New Rare-Disease Revenue Stream?
Posted by Surbhi on July 10 2026 at 05:32 PM   public
MEK inhibitors targeting neurofibromatosis type 1-associated plexiform neurofibromas — the oral allosteric MEK1/2 inhibitors selumetinib (Koselugo, AstraZeneca) and mirdametinib (Gomekli, SpringW...
arrow_forward